
Alfasigma USA, Inc.
Advertisement
Articles by Alfasigma USA, Inc.

Advertisement
Latest Updated Articles
Improving Response in Antidepressant Therapy: Focus on Deplin®November 10th 2021
Advertisement
Advertisement
Trending on Psychiatric Times
1
Ketamine for Treatment-Resistant Depression: Practical Clinical Considerations
2
sNDA Submitted: Caplyta for the Treatment of Bipolar Mania
3
Real-World Lecanemab Outcomes in Alzheimer Disease, Reported at 3 Years
4
Mixed Results From Phase 3 Data for AR1001 in Alzheimer Disease
5
